ClinicalTrials.gg
Not yet recruitingNCT07946172HIPMOUpdated Nov 18, 2026

Effectiveness of Online Gut-Directed Hypnotherapy and Movement Motivational and Self-management Training for Abdominal Pain Disorders in Adolescents

An interventional study of Gut-Focused Hypnosis Program and M3 Training in Chronic Abdominal Pain, sponsored by Bethesda Children's Hospital. Not yet recruiting at 1 site in Hungary. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Bethesda Children's Hospital · Not applicable, Interventional, and Treatment

Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
800
Allocation
Randomized
Ages
12 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-18

Among 13 studies in Motor Activity with a site in Hungary — 5 open to participants now, 5 under way, none of them phase 3. Motor Activity · Hungary.

Started
2026
the only one that year
No phase
3 of 13
1 open now
Registered
13th of 13
by date
Lead sponsor
1 of 13
Bethesda Children's Hospital

Among the 13 studies in Motor Activity with a site in Hungary, this one is the only one that started in 2026, is one of 3 with no phase, and was the 13th registered.

Motor Activity

9,824 studies on the registry are indexed under Motor Activity; 1,917 are open to participants now.

Browse Motor Activity studies →

Open to participants now

5 of the 13 studies in Motor Activity with a site in Hungary are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Hungary have not opened yet or have stopped. Only those recruiting at a site in Hungary →

Who these studies take

Of the 1,210 Motor Activity studies recruiting now, 522 (43%) set no upper age limit and 540 (45%) stop at 75 or younger; 180 take children under 18; 422 take healthy volunteers.

This study: 12 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Motor Activity with a site in Hungary, or all of them as a file.
02

Study summary

The present study is an online-based investigation involving adolescents with abdominal pain disorders, defined as recurrent abdominal pain persisting for at least two months. The study aims to evaluate the feasibility, acceptability, and effectiveness of online therapeutic interventions in comparison with usual pediatric gastroenterological care.

The study has two primary objectives. The first is to make two therapeutic interventions-Movement Motivation and Self-management Training (M3 Training) and gut-directed hypnotherapy-available online in Hungarian to young people with abdominal pain disorders and their families. Providing these interventions in an online format may facilitate easier and more timely access to therapeutic support for adolescents experiencing abdominal symptoms.

The second objective is to evaluate the effectiveness of the two online interventions. Specifically, the effectiveness of M3 Training and gut-directed hypnotherapy will be assessed both as individual interventions and in combination, and compared with usual pediatric gastroenterological care. This evaluation will assess whether the online interventions, delivered individually or in combination, offer effective therapeutic options for adolescents with abdominal pain disorders, focusing on both primary and secondary outcomes.

03

Conditions studied

  • Chronic Abdominal Pain

Browse trials for

Keywords

  • e-health
  • self-management
  • physical activity
  • gut-directed hypnosis
  • pediatric chronic pain
  • abdominal pain disorders
04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Following the minimum diagnostic work-up performed by a gastroenterologist, including:

  • celiac disease serology;
  • C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR);
  • complete blood count (CBC);
  • total protein;
  • albumin;
  • (AST; GOT);
  • alanine aminotransferase (ALT; GPT);
  • gamma-glutamyl transferase (GGT);
  • lactate dehydrogenase (LDH);
  • alkaline phosphatase (ALP);
  • urea;
  • creatinine;
  • iron studies;
  • urinalysis, at minimum using a urine dipstick;
  • fecal calprotectin or fecal occult blood testing.

Participants will be included in the study based on symptoms consistent with abdominal pain disorders according to the Rome V criteria and the following inclusion criteria:

  • Continuous or regularly recurrent abdominal pain persisting for at least 3 months.
  • No identifiable underlying organic disease that could explain the abdominal pain.
  • Able to care for themselves, capable of self-care and able to understand and follow the study procedures.
  • Able to read and write in Hungarian.
  • Has access to the internet.

Exclusion criteria

Exclusion Criteria:

  • Known severe psychiatric disorder
  • Epilepsy
  • Gastrointestinal disease requiring treatment and associated with pain symptoms
  • Proctalgia fugax
  • Intellectual disability.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ALT and AST (liver enzymes)

Two enzymes measured in a routine blood test of the liver. Higher levels can mean the liver is under strain or damaged. SGPT and SGOT are older names for ALT and AST.

Criteria usually give a limit as a multiple of the upper limit of normal (ULN), often higher when cancer has spread to the liver.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
800 participants (estimated)

Study arms

  • No intervention
    Standard care

    In the standard care control group, as in the intervention groups, participants will use an online platform (hasifajdalomkezeles.hu) to record their adherence to the treatment recommended by their gastroenterologist. The website does not include any therapeutic videos or active intervention. Its sole function is to support repeated online questionnaire-based data collection assessing treatment fidelity, adherence, and perceived effectiveness of the treatment. The primary and secondary outcome questionnaires become available at predefined time points over a 12-week period.

  • Experimental
    Gut-Focused Hypnosis Program

    The hypnosis arm is delivered through the same main study website (hasifajdalomkezeles.hu), presenting content developed based on the Dutch model of gut-directed hypnosis (www.hypnosis4abdominalpain.com), adapted with permission to Hungarian. The program is primarily based on video and audio materials and follows a predefined, standardised structure. The 12-week-long intervention content has a linear format consisting of sequential modules that introduce: the concept of abdominal pain disorders; the development of bowel hypersensitivity; the principles of medical hypnosis; and the role of hypnosis in the treatment of abdominal pain. This section is accompanied by weekly audio-based exercises that are designed to align with the original Dutch model. Adolescents are encouraged to complete the exercises that correspond to the weekly audio sessions, promoting deeper engagement and understanding of the material. The hypnosis website is non-adaptive and non-personalised.

    Behavioral: Gut-Focused Hypnosis Program

  • Experimental
    M3 Training

    M3 Training is a fully digitalised, 12-week online movement-motivation program delivered through the same website (hasifajdalomkezeles.hu). The previously developed and tested M3 Training program is fully adapted for digital delivery, with content specifically designed to support young people with chronic abdominal pain in developing their own movement program. During the first two weeks, the video series guides participants through the process of designing an individually developed movement program, which they then carry out over 3 months. From weeks 3 to 12, participants receive ongoing motivational videos and supporting materials aimed at maintaining engagement and supporting implementation of their movement plan. Throughout this period, participants are able to modify and further develop their movement program. Participants provide written responses to questions linked to the videos through the website, allowing them to reflect on their experiences and development throughout.

    Behavioral: M3 Training

  • Experimental
    Combined Hypnosis + M3 Training

    This arm represents an integrated version of the hypnosis program and M3 Training, combining the two existing interventions into a single 12-week online program. Users access both therapeutic components through the same website (hasifajdalomkezeles.hu). During the 12-week-long joint program the hypnosis-related content and the M3 Training videos are released according to a coordinated schedule. The aim is not simply to provide the two interventions in parallel, but to achieve structured integration, ensuring that the two approaches complement one another.

    Behavioral: Gut-Focused Hypnosis Program · Behavioral: M3 Training

Interventions

  • BehavioralGut-Focused Hypnosis Program

    The hypnosis arm is delivered through the same main study website (hasifajdalomkezeles.hu), presenting content developed based on the Dutch model of gut-directed hypnosis ( www.hypnosis4abdominalpain.com), adapted with permission to Hungarian. The program is primarily based on video and audio materials and follows a predefined, standardised structure. The 12-week-long intervention content has a linear format consisting of sequential modules that introduce: the concept of abdominal pain disorders; the development of bowel hypersensitivity; the principles of medical hypnosis; and the role of hypnosis in the treatment of abdominal pain. This section is accompanied by weekly audio-based exercises that are designed to align with the original Dutch model. Adolescents are encouraged to complete the exercises that correspond to the weekly audio sessions, promoting deeper engagement and understanding of the material. The hypnosis website is non-adaptive and non-personalised.

  • BehavioralM3 Training

    M3 Training is a fully digitalised, 12-week online movement-motivation program delivered through the same website (fasifajdalomkezeles.hu). The previously developed and tested M3 Training program is fully adapted for digital delivery, with content specifically designed to support young people with chronic abdominal pain in developing their own movement program. During the first two weeks, the video series guides participants through the process of designing an individually developed movement program, which they then carry out over 3 months. From weeks 3 to 12, participants receive ongoing motivational videos and supporting materials aimed at maintaining engagement and supporting implementation of their movement plan. Throughout this period, participants are able to modify and further develop their movement program. Participants provide written responses to questions linked to the videos through the website, allowing them to reflect on their experiences and development throughout.

06

What researchers measure

Primary outcomes

  1. Pain intensity (proportion of patients with ≥30% improvement in abdominal pain) measured by Numerical Rating Scale

    ≥30% reduction in pain intensity is our main outcome. Pain intensity will be assessed using an 11-point Numerical Rating Scale (NRS; 0-10), which is a validated measure of self-reported pain intensity in children and adolescents (Miró et al., 2009).

    Time frame: From enrollment to the end of treatment at 12 weeks.

  2. Quality of Life measured by The Pediatric Quality of Life Inventory

    The Pediatric Quality of Life Inventory (PedsQL) is a validated questionnaire designed to assess health-related quality of life in children and adolescents.

    Time frame: From enrollment to the end of treatment at 12 weeks

Secondary outcomes

  1. Functional Disability assessed by Functional Disability Inventory

    The Functional Disability Inventory (FDI) is a 15-item self-report measure assessing limitations in everyday physical, social, and school-related activities. It has been extensively validated in children and adolescents, including a large sample of 596 patients aged 8-17 years with chronic abdominal pain (Walker \& Greene, 1991; Claar \& Walker, 2006). Both the child and parent versions of the questionnaire will be administered.

    Time frame: From enrollment to the end of treatment at 12 weeks

  2. Anxiety and Depression measured by Revised Children's Anxiety and Depression Scale (RCADS)

    The Revised Children's Anxiety and Depression Scale (RCADS) is a 47-item self-report questionnaire assessing symptoms of anxiety and depression in children and adolescents and has demonstrated good psychometric properties in both community and clinical populations (Chorpita et al., 2000; Chorpita et al., 2005). Both the child and parent versions of the questionnaire will be administered.

    Time frame: From enrollment to the end of treatment at 12 weeks

  3. Gastrointestinal symptom-specific anxiety measured by Visceral Sensitivity Index

    The original Visceral Sensitivity Index (VSI) is a 15-item, unidimensional self-report questionnaire developed to assess gastrointestinal symptom-specific anxiety-that is, anxiety, worry, and fear related to gastrointestinal sensations, symptoms, and the situations in which these symptoms may occur. It was developed and validated in 96 adult patients with irritable bowel syndrome (IBS) and showed excellent reliability together with good content, convergent, divergent, and predictive validity (Labus et al., 2004). Both the child and parent versions of the questionnaire will be administered.

    Time frame: From enrollment to the end of treatment at 12 weeks

  4. Different cognitive, behavioural, and interpersonal strategies used by children to cope with pain assessed by Pain Coping Questionnaire

    The Pain Coping Questionnaire (PCQ) is a 39-item self-report measure assessing different cognitive, behavioural, and interpersonal strategies used by children to cope with pain. It was developed for children and adolescents and has been validated from approximately 8 years of age, including populations with recurrent pain (Reid et al., 1998). Both the child and parent versions of the questionnaire will be administered.

    Time frame: From enrollment to the end of treatment at 12 weeks

  5. Missing school days collected from parents

    School absence will be assessed as the parent-reported number of school days missed because of abdominal pain or gastrointestinal symptoms during a predefined recall period. Both the child and parent versions of the questionnaire will be administered.

    Time frame: From enrollment to the end of treatment at 12 weeks

  6. Sleep characteristics assessed using study-specific self-report items

    Sleep characteristics will be assessed using study-specific self-report items covering perceived sleep quality, average nightly sleep duration, and frequency of daytime naps.

    Time frame: From enrollment to the end of treatment at 12 weeks

  7. Intervention Satisfaction and Patient Global Impression of Change assessed by open-ended question

    Patient satisfaction will be explored using the following open-ended question: "What story would you tell your best friend about your experience with the therapy over the past 12 weeks?" Patient Global Impression of Change will be measured through the following question: Since the start of the study, my overall status is: options range from "Very Much Improved" to "Very Much Worse" Both the child and parent versions of the questionnaire will be administered.

    Time frame: From enrollment to the end of treatment at 12 weeks

  8. Website engagement collected via webpage

    Website monitoring will include the number and timing of logins, the duration and frequency of listening to the audio recordings, the duration and frequency of viewing the M3 videos, whether each audio recording was listened to at least once, whether each video was viewed at least once, and whether all questions were answered; if not, the number and identity of unanswered questions will also be recorded.

    Time frame: From enrollment to the end of treatment at 12 weeks

  9. Adequate Relief of Abdominal Pain and/or Discomfort assessed using a single dichotomous (yes/no) question.

    Proportion of participants reporting adequate relief of abdominal pain and/or discomfort during the preceding week compared with baseline, assessed using a single dichotomous (yes/no) question.

    Time frame: From enrollment to the end of treatment at 12 weeks

Other outcomes

  1. Adverse event assessed by open-ended questions

    Adverse events will be monitored prospectively throughout the intervention period. An adverse event will be defined as any new or worsening unfavourable physical or psychological health-related occurrence during study participation, irrespective of whether it is considered to be related to the intervention. At each scheduled assessment, participants will be asked about any new or worsening health-related problems since the previous assessment. If an adverse event is reported, a brief description of the event, its impact on daily activities, whether medical attention was required, and whether it resulted in modification or discontinuation of the intervention will be recorded. Reported events will subsequently be reviewed by the study team with respect to severity, seriousness, expectedness, and possible relatedness to the intervention (Junqueira et al., 2023; Burns et al., 2024). Both the child and parent versions of the questionnaire will be administered.

    Time frame: From enrollment to the end of treatment at 12 weeks

07

Study locations

1 site
  • HRC Bethesda Children's Hospital
    Budapest, Budapest 1146, Hungary
    • János Major, MD, PhD · Contactmajor.janos@bethesda.hu · +36303306298
    • Adrienn Vargay, PhD · Sub investigator
    • Katalin Forgács-Kristóf, MSc · Sub investigator
    • Sára Bencsik, MD · Sub investigator
    • Nándor Hajdú, PhD · Sub investigator
    • Katalin Eszter Müller, MD, PhD · Sub investigator
08

References and documents

Related links

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2026; primary completion for Dec 2030, 48 months later.

Of 5,170 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 48 months is above that.

Counting every sponsor, half of 5,230 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 12, 2026
First posted
Nov 18, 2026
StartEst.
Dec 2026
Primary completionEst.
Dec 2030
CompletionEst.
Dec 2030
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07946172
Lead sponsor
Bethesda Children's Hospital
Collaborators
Semmelweis University, Eotvos Lorand University, Heim Pal Children's Hospital
Responsible party
János Major (Head of Department, Paediatric Pain Centre Medical Director, Bethesda Children's Hospital, Bethesda Children's Hospital) — Principal investigator
First posted
Nov 18, 2026
Start date
Dec 2026 (estimated)
Primary completion
Dec 2030 (estimated)
Completion
Dec 2030 (estimated)
Last update
Nov 18, 2026

Study contacts

János Major, MD, PhD
Contact
major.janos@bethesda.hu
+36303306298

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion